Middle East Conflict Disrupts Global Pharmaceutical Supply Chains

• •The Middle East conflict is disrupting critical pharmaceutical supply chains.
• •UK could face medicine shortages in weeks if the conflict continues.
• •Air freight costs have doubled, impacting drug prices and availability.

The ongoing conflict in the Middle East, triggered by US-Israeli military strikes on Iran on February 28, 2026, is severely disrupting pharmaceutical supply chains. Key air freight routes have been compromised due to the closure of major aviation hubs like Dubai, Abu Dhabi, and Doha, which are critical for global cargo movements. Experts warn that the UK could face medicine shortages in just a few weeks if the conflict persists, affecting everything from painkillers to cancer treatments. The strait of Hormuz's near-total closure further complicates shipping routes, leading to increased costs and potential drug shortages. Pharmaceutical companies are rerouting shipments through alternative routes, but these options are slower and riskier, particularly for temperature-sensitive biologics. The rising costs of air freight, which have doubled, may force companies to pass on expenses to patients. Current stockpiles are adequate for now, but the situation remains precarious as the conflict continues.